Report: FDA approved the most drugs in 4 years in 2009

01/5/2010 | Wall Street Journal, The

The FDA approved 26 new treatments in 2009, the most in four years but only one more than in 2008, according to a Washington Analysis report. Blood thinner Effient, by Eli Lilly and Co. and Daiichi Sankyo, and Sanofi-Aventis' heart drug Multaq were among the approvals, while Novo Nordisk's liraglutide for diabetes and Amgen's osteoporosis drug denosumab failed to secure approval.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT